Michael Cloonan

Sage Therapeutics

Chief Business Officer

Overview

Annual data

2017

Bonus$125,000
Non-Equity Incentive Plan$170,016
Option Awards$9,439,278
Salary$301,795
Other$7,655
Total$10,043,744

In 2017, Michael Cloonan earned a total compensation of $10,043,744 as Chief Business Officer at Sage Therapeutics, Inc..

Cloonan received $9,439,278 in option awards, which accounts for 93.98% of total compensation.

Cloonan also received $125,000 in bonus, $170,016 in non-equity incentive plan, $301,795 in salary and $7,655 in other compensation.